Latest – Neuralink Brain Chip Approved For Human Implant
Elon Musk’s venture, Neuralink, has secured authorization to commence its inaugural human trial involving brain implants, specifically targeting paralysis due to spinal injuries or ALS.
The brain-implant venture spearheaded by the renowned business magnate Elon Musk, Neuralink, has been granted the green light to launch its initial human experiments. The research is set to concentrate on individuals afflicted by paralysis as a result of injuries to the cervical spine or the condition known as amyotrophic lateral sclerosis (ALS). The official declaration was made on September 19, though the exact count of participants has yet to be revealed.
Previously, Neuralink had aspirations to get a thumbs up for a group of 10 individuals. However, following safety reservations voiced by the U.S. Food and Drug Administration (FDA), the firm had to recalibrate its expectations toward a more limited participant count.
The exact number that the FDA has given the go-ahead for remains unclear. This news emerges subsequent to Neuralink receiving approval for its pioneering human trial last May. It’s worth noting that during this period, the company was also scrutinized regarding its practices in animal testing.
Industry specialists speculate on the project’s trajectory
, positing that even if the Brain-Computer Interface (BCI) implant is deemed harmless for human use, it might take ten years or possibly longer before it’s sanctioned for broader commercial application, as cited by Reuters.Musk’s grand vision for Neuralink transcends merely addressing paralysis. He envisions a swift surgical procedure to implant chip devices that could potentially address a gamut of ailments ranging from obesity and autism to mood disorders and cognitive impairments.
Central to this groundbreaking trial is a sophisticated surgical technique where a robotic system positions the BCI implant into a designated brain region associated with movement intentions. The primary objective is clear-cut: empower participants to interface with a computer or navigate a cursor purely via cognitive commands.
The duration of this clinical experiment is projected to be around six years, setting the stage for an in-depth analysis of the implant’s reliability and effectiveness. While there’s a cloud of uncertainty surrounding it, this initiative prompts deeper reflection on the potential of leveraging technology to tackle intricate health challenges.
Latest – Neuralink Brain Chip Approved For Human Implant
